Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

C Am Pfield Therapeutics Appoints Graham Heap As President, R&D

PRIVATEAug 03, 2026•6 days ago

Position

President

Company

cAMPfield Therapeutics

Graham Heap, MD, PhD
San DiegoBiotechnologyHealth Care

Description

cAMPfield Therapeutics has announced the appointment of Graham Heap as President of Research and Development, among other key executive roles. This leadership enhancement comes as the company advances its lead therapy, prifemilast, into global trials for ulcerative colitis and Crohn's disease.

Company Information

Company

cAMPfield Therapeutics

Location

San Diego, California, United States

About

cAMPfield Therapeutics is a biotech company focused on developing oral medicines for inflammatory bowel diseases (IBD). Recently launched with a $180 million series A funding round, the company is advancing its lead candidate, prifemilast, through global clinical trials. The company aims to establish a new standard of care in treating IBD by leveraging selective PDE4 inhibition. Founded by industry veterans and backed by prominent investors, cAMPfield represents a new model in biotech originating from China.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for cAMPfield Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.